Physician profile
Connie Casad
NPI 1376544296
$1,184.82
in general payments reported to CMS, 2019-2025
18 companies · $14.78 in 2025
The $14.78 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $210 · 2021: $300 · 2022: $133 · 2023: $148 · 2024: $58.75 · 2025: $14.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160 · Education: $61.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.77 |
| Education | $61.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $323.00 | 2019-2024 | |
| Astellas Pharma US INC | $181.14 | 2021-2023 | Veozah |
| Allergan, INC. | $138.42 | 2019-2021 | |
| Abbvie INC. | $92.04 | 2019-2023 | |
| Novo Nordisk INC | $77.22 | 2020-2021 | |
| Therapeuticsmd, INC. | $76.66 | 2019-2022 | |
| Virtus Pharmaceuticals LLC | $55.89 | 2022 | |
| Ibsa Pharma INC. | $48.60 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $35.94 | 2019 | |
| Corcept Therapeutics | $34.57 | 2024-2025 | Korlym |
| Myovant Sciences INC. | $19.73 | 2021 | |
| Lilly USA, LLC | $19.15 | 2024 | Zepbound |
| Eisai INC. | $18.38 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.23 | 2023 | Adthyza |
| Exact Sciences Corporation | $12.73 | 2023 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.63 | 2019 | |
| Ascend Therapeutics US, LLC | $11.31 | 2021 | |
| Acella Pharmaceuticals, LLC | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Casad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.